[Research Progress in Pathogenesis of Hypertension in Acute Intermittent Porphyria]

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Feb;45(1):129-133. doi: 10.3881/j.issn.1000-503X.14571.
[Article in Chinese]

Abstract

Acute intermittent porphyria (AIP) has complicated clinical manifestations and is often accompanied by hypertension.AIP may cause hypertension through adrenergic effect,heme deficiency,inflammation,inappropriate secretion of antidiuretic hormone,toxicity of delta-aminolevulinic acid(ALA,aporphyrin precursor),and elevated serum glucose level.The prevention and treatment strategies for AIP accompanied with hypertension mainly include the controlling of porphyria attacks,application of antihypertensive drugs,lifestyle intervention,and management of latent AIP patients.

Keywords: acute intermittent porphyria; hypertension; porphyria; secondary hypertension.

Publication types

  • English Abstract

MeSH terms

  • Blood Glucose
  • Humans
  • Hypertension* / etiology
  • Inflammation
  • Life Style
  • Porphyria, Acute Intermittent*

Substances

  • Blood Glucose